Macquarie Group’s Aehr Test Systems AEHR Stock Holding History

Macquarie Group’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-681	Closed	-$21K	–	1655
2023 Q1	$21K	Hold	681	–	–	﹤0.01%	1669
2022 Q4	$14K	Buy	+681	New	+$14.6K	﹤0.01%	1707

Other funds holding AEHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group's AEHR Position: Q2 2023 in Review

Macquarie Group sold out of Aehr Test Systems (AEHR) in Q2 2023, closing a stake of 681 shares — an estimated $21K sold.

Macquarie Group first reported a position in AEHR in Q4 2022 and held it in 2 quarters. The position peaked at $21K in Q1 2023. 151 funds tracked by Wall St. Rank hold AEHR as of Q2 2023.

Macquarie Group reported no remaining Aehr Test Systems position as of Q2 2023 after selling out during the quarter.
Macquarie Group sold 681 Aehr Test Systems shares in Q2 2023, an estimated $21K.
Macquarie Group first reported a position in Aehr Test Systems in Q4 2022 and held it in 2 quarters.
Macquarie Group's Aehr Test Systems position peaked at $21K in Q1 2023.
151 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2023.

Based on Macquarie Group's 13F filing for Q2 2023, filed 14 Aug 2023.